Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaP

Cytogenetic and Genome Research

Volumn 112, Issue 1-2, 2006, Pages 45-52

  Strefford, J C ^a,d   Lane, T M ^a   Hill, A ^a   LeRoux, L ^a   Foot, N J ^a   Shipley, J ^b   Oliver, R T D ^c   Lu, Y J ^a   Young, B D ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOWN REGULATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; GENE TRANSLOCATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA;

BASE SEQUENCE; BLOTTING, SOUTHERN; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CHROMOSOME BANDING; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 15; DNA PRIMERS; HUMANS; IMMEDIATE-EARLY PROTEINS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 27644507085     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087512     Document Type: Article

References (61)

1. Aaltoma SH, Lipponen PK, Kosma VM: Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Anticancer Res 21:3101-3106 (2001).
2. Adelaide J, Huang HE, Murati A, Alsop AE, Orsetti B, Mozziconacci MJ, Popovici C, Ginestier C, Letessier A, Basset C, et al: A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene. Genes Chromosomes Cancer 37:333-345 (2003).
3. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF: CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95:6355-6360 (1998).
4. Barlund M, Monni O, Weaver JD, Kauraniemi P, Sauter G, Heiskanen M, Kallioniemi OP, Kallioniemi A: Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes Chromosomes Cancer 35:311-317 (2002).
5. Barrans JD, Ip J, Lam CW, Hwang IL, Dzau VJ, Liew CC: Chromosomal distribution of the human cardiovascular transcriptome. Genomics 81:519-524 (2003).
6. Beheshti B, Karaskova J, Park PC, Squire JA, Beatty BG: Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by spectral karyotyping. Mol Diagnosis 5:23-32 (2000).
7. Boucheix C, Rubinstein E: Tetraspanins. Cell Mol Life Sci 58:1189-1205 (2001).
8. Boutanaev AM, Kalmykova AI, Shevelyov YY, Nurminsky DI: Large clusters of co-expressed genes in the Drosophila genome. Nature 420:666-669 (2002).
9. Carozzi F, Lombardi FC, Zendron P, Confortini M, Sani C, Bisanzi S, Pontenani G, Ciatto S: Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers 19:257-261 (2004).
10. Charny CK, Glick RD, Genega EM, Meyers PA, Reuter VE, La Quaglia MP: Ewing's sarcoma/primitive neuroectodermal tumor of the ureter: a case report and review of the literature. J Pediatr Surg 35:1356-1358 (2000).
11. Chen H, Toyooka S, Gazdar AF, Hsieh JT: Epigenetic regulation of a novel tumor suppressor gene (hDAB21P) in prostate cancer cell lines. J Biol Chem 278:3121-3130 (2003).
12. Chen JJ, Reid CE, Band V, Androphy EJ: Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269:529-531 (1995).
13. Chu LW, Troncoso P, Johnston DA, Liang JC: Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer. Genes Chromosomes Cancer 36:303-312 (2003).
14. Cong F, Spencer S, Cote JF, Wu Y, Tremblay ML, Lasky LA, Goff SP: Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation. Mol Cell 6:1413-1423 (2000).
15. Debiec-Rychter M, Marynen P, Hagemeijer A, Pauwels P: ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 38:187-190 (2003).
16. Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC, Isaacs JT: Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 56:4387-4390 (1996).
17. Dumur CI, Dechsukhum C, Ware JL, Cofield SS, Best AM, Wilkinson DS, Garrett CT, Ferreira-Gonzalez A: Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics 81:260-269 (2003).
18. French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA: BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 63:304-307 (2003).
19. Gibas Z, Becher R, Kawinski E, Horoszewicz J, Sandberg AA: A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP). Cancer Genet Cytogenet 11:399-404 (1984).
20. Gotter J, Brors B, Hergenhahn M, Kyewski B: Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J Exp Med 199:155-166 (2004).
21. Heimann P, El Housni H, Ogur G, Weterman MA, Petty EM, Vassart G: Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas. Cancer Res 61:4130-4135 (2001).
22. Kallioniemi A, Kallioniemi O-P, Sudar D: Comparative genomic hybridisation for molecular genetic analysis of solid tumours. Science 258:818-821 (1992).
23. Kanoe H, Nakayama T, Hosaka T, Murakami H, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Ron D, Sasaki MS, et al: Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation. Oncogene 18:721-729 (1999).
24. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS, Lau LF: Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res 233:63-77 (1997).
25. Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K: Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 82:1897-1903 (1998).
26. Knezevich SR, Garnett MJ, Pysher TJ, Beckwith JB, Grundy PE, Sorensen PH: ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 58:5046-5048 (1998a).
27. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH: A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184-187 (1998b).
28. Lu YJ, Williamson D, Clark J, Wang R, Tiffin N, Skelton L, Gordon T, Williams R, Allan B, Jackman A, et al: Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression. Proc Natl Acad Sci USA 98:9197-9202 (2001).
29. Medeiros RM, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Ferreira P, Lopes C: Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clin Cancer Res 8:3433-3437 (2002).
30. Minagawa S, Nakabayashi K, Fujii M, Scherer SW, Ayusawa D: Functional and chromosomal clustering of genes responsive to 5-bromodeoxyuridine in human cells. Exp Gerontol 39:1069-1078 (2004).
31. O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, et al: Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Eng J Med 348:994-1004 (2003).
32. Pan Y, Kytola S, Farnebo F, Wang N, Lui WO, Nupponen N, Isola J, Visakorpi T, Bergerheim US, Larsson C: Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping. Cytogenet Cell Genet 87:225-232 (1999).
33. Park KR, Inoue T, Ueda M, Hirano T, Higuchi T, Konishi I, Fujiwara H, Fujii S: Anti-CD9 monoclonal antibody-stimulated invasion of endometrial cancer cell lines in vitro: possible inhibitory effect of CD9 in endometrial cancer invasion. Mol Hum Reprod 6:719-725 (2000).
34. Pilarsky CP, Schmidt U, Eissrich C, Stade J, Froschermaier SE, Haase M, Faller G, Kirchner TW, Wirth MP: Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer. Prostate 36:85-91 (1998).
35. Pinkel D, Gray JW, Trask B, van den Engh G, Fuscoe J, van Dekken H: Cytogenetic analysis by in situ hybridization with fluorescently labeled nucleic acid probes. Cold Spring Harb Symp Quant Biol 51:151-157 (1986).
36. Radford KJ, Thorne RF, Hersey P: CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. Biochem Biophys Res Commun 222:13-18 (1996).
37. Radford KJ, Thorne RF, Hersey P: Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 158:3353-3358 (1997).
38. Redner RL, Wang J, Liu JM: Chromatin remodeling and leukemia: new therapeutic paradigms. Blood 94:417-428 (1999).
39. Roy PJ, Stuart JM, Lund J, Kim SK: Chromosomal clustering of muscle-expressed genes in Caenorhabditis elegans. Nature 418:975-979 (2002).
40. Solinas-Toldo S, Wallrapp C, Muller-Pillasch F, Bentz M, Gress T, Lichter P: Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 56:3803-3807 (1996).
41. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517 (1975).
42. Spencer S, Dowbenko D, Cheng J, Li W, Brush J, Utzig S, Simanis V, Lasky LA: PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase. J Cell Biol 138:845-860 (1997).
43. Spitz F, Gonzalez F, Duboule D: A global control region defines a chromosomal regulatory landscape containing the HoxD cluster. Cell 113:405-417 (2003).
44. Strefford JC, Lillington DM, Young BD, Oliver RTD: The use of multi-colour fluorescence technologies in the characterisation of prostate carcinoma cell lines: A comparison of multiplex-FISH and spectral karyotyping data. Cancer Genet Cytogenet 124:112-121 (2001).
45. Sugiura T, Berditchevski F: Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J Cell Biol 146:1375-1389 (1999).
46. Todd SC, Doctor VS, Levy S: Sequences and expression of six new members of the tetraspanin/TM4SF family. Biochim Biophys Acta 1399:101-104 (1998).
47. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, et al: Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2:367-376 (2002).
48. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, et al: t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33:208-213 (2003).
49. Tran CT, Fox MF, Vallance P, Leiper JM: Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics 68:101-105 (2000).
50. Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R: Cyr61 promotes breast tumorigenesis and cancel-progression. Oncogene 21:8178-8185 (2002).
51. van Bokhoven A, Caires A, Maria MD, Schulte AP, Lucia MS, Nordeen SK, Miller GJ, Varella-Garcia M: Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines. Prostate 57:226-244 (2003).
52. Veronese ML, Bullrich F, Negrini M, Croce CM: The t(6;16)(p21;q22) chromosome translocation in the LNCaP prostate carcinoma cell line results in a tpc/hpr fusion gene. Cancer Res 56:728-732 (1996).
53. Wang XZ, Jolicoeur EM, Conte N, Chaffanet M, Zhang Y, Mozziconacci MJ, Feiner H, Birnbaum D, Pebusque MJ, Ron D: gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line. Oncogene 18:5718-5721 (1999).
54. Watanabe N, Kobayashi H, Hirama T, Kikuta A, Koizumi S, Tsuru T, Kaneko Y: Cryptic t(12;15) (p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of 1GF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis. Cancer Genet Cytogenet 136:10-16 (2002).
55. Wei Y, Sun M, Nilsson G, Dwight T, Xie Y, Wang J, Hou Y, Larsson O, Larsson C, Zhu X: Characteristic sequence motifs located at the genomic breakpoints of the translocation t(X;18) in synovial sarcomas. Oncogene 22:2215-2222 (2003).
56. Weterman MA, Wilbrink M, Dijkhuizen T, van den Berg E, Geurts van Kessel A: Fine mapping of the 1q21 breakpoint of the papillary renal cell carcinoma-associated (X;1) translocation. Hum Genet 98:16-21 (1996).
57. Willis TG, Jadayel DM, Coignet IJ, Abdul-Rauf M, Treleaven JG, Catovsky D, Dyer MJ: Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polmerase chain reaction. Blood 90:2456-2464 (1997).
58. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP: Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res 64:1987-1996 (2004).
59. Yang GP, Lau LF: Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ 2:351-357 (1991).
60. Yasunaga Y, Nakamura K, Ko D, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Rhim JS: A novel human cancer culture model for the study of prostate cancer. Oncogene 20:8036-8041 (2001).
61. Zemni R, Bienvenu T, Vinet MC, Sefiani A, Carrie A, Billuart P, McDonell N, Couvert P, Francis F, Chafey P, et al: A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet 24:167-170 (2000).